Morningstar® Investment Profile™   Morningstar® Disclosure   Format for Print Invesco VI Health Care I Release date as of 2024-03-31. Data on page is subject to change. Snapshot Ratings & Risk Portfolio Nuts & Bolts

Morningstar Report Overall Morningstar Rating™ What is this? As of 2024-03-31 Out of 159 Health Funds Morningstar® Style Box™ What is this? As of 2024-02-29 Total Fund Assets ($ Mil) 191.92 View Historical Morningstar Star Ratings and Definitions

Investment Objective & Strategy   The investment seeks long-term growth of capital. The fund invests at least 80% of its net assets (plus any borrowings for investment purposes) in securities of issuers engaged primarily in health care-related industries, and in derivatives and other instruments that have economic characteristics similar to such securities. It invests primarily in equity securities, including common and preferred stock, and depositary receipts. The fund may invest in securities of foreign issuers including up to 20% of its net assets in securities of issuers located in emerging markets countries, i.e., those that are in the early stages of their industrial cycles.

Morningstar Category: Health Health portfolios focus on the medical and health-care industries. Most invest in a range of companies, buying everything from pharmaceutical and medical-device makers to HMOs, hospitals, and nursing homes. A few portfolios concentrate on just one industry segment, such as service providers or biotechnology firms.

Investment Risks Sector Funds: Funds that invest exclusively in one sector or industry involve risks due to the lack of industry diversification and expose the investor to increased industry-specific risks.

Portfolio Profile Asset Allocation % of Net Assets U.S. Stocks 90.7 Non-U.S. Stocks 7.2 Bonds 0.0 Cash 2.1 Other 0.0 Data through 2024-02-29 Morningstar Equity Sectors % of Stocks Cyclical 0.36 Basic Materials 0.00 Consumer Cyclical 0.00 Financial Services 0.00 Real Estate 0.36 Sensitive 0.00 Communication Services 0.00 Energy 0.00 Industrials 0.00 Technology 0.00 Defensive 99.64 Consumer Defensive 0.00 Healthcare 99.64 Utilities 0.00 Data through 2024-02-29 Holding Status Total Number of Stock Holdings 87 Total Number of Bond Holdings 0 % of Net Assets in Top 10 Holdings 45.16 Turnover % (as of 2023-12-31) 57.00 30 Day SEC Yield % --- Top Holdings Sector P/E % of Net Assets Eli Lilly and Co 134.13 8.92 UnitedHealth Group Inc 20.73 6.10 Boston Scientific Corp 64.01 5.22 McKesson Corp 24.27 4.11 Vertex Pharmaceuticals Inc 30.09 3.78 Merck & Co Inc 942.50 3.56 Stryker Corp 43.38 3.54 Regeneron Pharmaceuticals Inc 27.68 3.53 Intuitive Surgical Inc 79.34 3.20 Thermo Fisher Scientific Inc 37.62 3.20 Data through 2024-02-29

Principal Risks    Emerging Markets, Foreign Securities, Loss of Money, Not FDIC Insured, Active Management, Issuer, Market/Market Volatility, Depositary Receipts, Equity Securities, Industry and Sector Investing, Preferred Stocks, Derivatives, Small Cap, Mid-Cap Show Risk Definitions

Other Information Inception Date: 1997-05-21 Portfolio Manager(s) Justin J. Livengood   (2020-12-18) Mr. Livengood has been a Vice President of OppenheimerFunds since May 2006 and a Senior Portfolio Manager since January 2014. He was a Senior Research Analyst from May 2006 to January 2014, responsible for the health care, energy and financial services sectors for mid- and small-cap growth accounts. Before joining OppenheimerFunds in May 2006, Mr. Livengood was a vice president and fund analyst with Merrill Lynch Investment Managers. During his tenure at Merrill Lynch he also worked as an investment banking analyst in the Global Media Group and as an associate with Merrill Lynch Ventures. Investment Advisor(s) Invesco Advisers, Inc. Issuer Invesco Subadvisor(s) ---

Show Data Definitions © Copyright 2024 Morningstar, Inc. All rights reserved. Morningstar, the Morningstar logo, Morningstar.com, Morningstar Tools are either trademark or service marks of Morningstar, Inc. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or any losses arising from any use of information. Past performance is no guarantee of future performance. Past performance is no guarantee of future results. Returns will vary and shares may be worth more or less than their original cost when sold.